ClinicalTrials.Veeva

Menu

The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula (NLR)

I

Institut Paoli-Calmettes

Status

Completed

Conditions

Pancreas Neoplasm

Treatments

Procedure: pancreatoduodenectomy (PD)

Study type

Observational

Funder types

Other

Identifiers

NCT04724551
NLR-IPC 2020-058

Details and patient eligibility

About

There is still no consensus on whether drain fluid amylase (DFA) level, C-reactive protein (CRP) level, or complex scores predict clinically relevant postoperative pancreatic fistula (CR-POPF). The aim of this study is to determine the accuracy of simple biochemical parameters (leucocytes, neutrophils, lymphocytes, Neutrophil to Lymphocytes Ratio (NLR), at postoperative days 1 and 3) to exclude the diagnosis of CR-POPF.

Full description

From January 1, 2012 to December 31, 2020, consecutive patients underwent PD performed at Institut Paoli-Calmettes for various pathologies. Data were entered prospectively into a clinical database (NCT02871336).

The cohort was split into 3 groups:

  • a training cohort ;
  • an internal validation cohort (Paoli Calmettes institute);
  • an external validation cohort (Rennes Pontchaillou Hospital).

Enrollment

648 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who underwent pancreatoduodenectomy

Exclusion criteria

  • Total pancreatectomy
  • Enucleation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems